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(1-36) or PTHrP (107-139) (100 nM) for 1.5 h. The cell density over the
support was 50,000 cells/cm2. We performed 18 groups: 9 in normoxia
(humidiﬁed atmosphere with 5% CO2) and the other 9 in hypoxia condi-
tions (obtained with GasPak™ EZ Anaerobe Pouch System, BD Diagnostics)
(see table 1). Within each group, 5 replicas were done. The study period
was 14 days for the groups tested in hypoxia and 21 days for those in
normoxia. BM-MSCs were cultured in chondrogenic differentiation medium
(Lonza, Group Ltd, Switzerland) or DMEM with 20% FBS. Control groups
(VII, VIII and IX) were mature human chondrocytes grown in DMEM with
10% FBS. Chondrogenic differentiation was conﬁrmed by histochemical and
immunohistochemical analysis, and transmission and scanning electronic
microscopy.
Results: BM-MSCs and chondrocytes were able to grow on equine type
I collagen supports, with or without the presence of PTHrP fragments,
producing extracellular matrix. Both cell types showed their typical
morphology; their phenotypes were conﬁrmed by SOX2 and OCT3/4 im-
munoﬂuorescence analysis, in the case of BM-MSCs, and by Masson’s
trichrome stainings for proteoglycans and immunostainings to detect the
presence of type II collagen, in the case of chondrocytes. BM-MSCs (groups
I to III) grown on the collagen substrate were able to differentiate into
chondrocyte-like cells which were positive for Masson’s trichrome and
type II collagen. However, chondrogenesis was more evident in cultures
treated with the PTHrP fragments. Electronic microscopy revealed that the
latter cultures showed a large amount of lipid or glycoprotein vacuoles,
many ribosomes and a large endoplasmic reticulum, characteristic of the
cells with a high activity. These differentiating BM-MSCs also showed many
extensions that might secrete adhesion molecules to adhere to the collagen
support.
Table 1. Groups of study in normoxia and hypoxia conditions
Group Cells PTHrP treatment Culture medium
Group I BM-MSCs C-terminal fragment Chondrogenic
Group II BM-MSCs N-terminal fragment Chondrogenic
Group III BM-MSCs No treatment Chondrogenic
Group IV BM-MSCs C-terminal fragment DMEM + 20% FBS
Group V BM-MSCs N-terminal fragment DMEM + 20% FBS
Group VI BM-MSCs No treatment DMEM + 20% FBS
Group VII Chondrocytes C-terminal fragment DMEM + 10% FBS
Group VIII Chondrocytes N-terminal fragment DMEM + 10% FBS
Group IX Chondrocytes No treatment DMEM + 10% FBS
Figure 1. Immunohistochemistry analysis of BM-MSCs (group II) grown on pure equine
type I collagen supports in normoxia conditions.
Conclusions: Our data demonstrate that pure equine type I collagen sup-
ports are optimal for BM-MSCs and chondrocyte growth. Moreover, both
N- and C-terminal fragments of PTHrP improve the capacity of BM-MSCs to
differentiate into chondrocyte-like cells.
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Purpose: Mesenchymal stem cells (MSCs) are an accepted candidate for
cell-based therapy of rheumatic diseases. Recently, like aggregation and
TGF-beta delivery, hypoxia has been indicated as crucial for complete
chondrogenesis. The aim of this study was to analyze bone marrow MSCs
(BM-MSCs) differentiation capacity under normoxic and hypoxic culture
conditions.
Methods: MSCs, isolated from bone marrow stroma (n= 3) and expanded
in monolayer cultures, were characterized by ﬂow cytometry and differen-
tiated towards adipocytes, osteoblasts and chondrocytes under normoxic
or hypoxic conditions using commercial differentiation medium. The dif-
ferentiations were conﬁrmed by histochemical, immunohistochemical and
qPCR analysis comparing each treated point with a control point made of
cells grown in DMEM and FBS.
Results: BM-MSCs from the three donors displayed only few phenotypical
differences in surface antigens expressions. Analyzing marker genes ex-
pression levels of the treated cells (T.C.) compared to its control point (CTL)
for each lineage showed a good differentiation in normoxic conditions and
the absence of this differentiation capacity in hypoxic cultures (as shown
in the table). Histochemical analysis conﬁrmed these results.
For each gene, the reference value 1 is given to its expression level in the control point
Lineage Gene Normoxic Condition Hypoxic Condition
CTL T.C. CTL T.C.
Adipogenic LPL 1,00 972,13 1,00 1,92
FABP4 1,00 48934,74 1,00 0,14
AMP1 1,00 1247,03 1,00 3,64
Osteogenic ALP 1,00 19,14 1,00 1,73
OP 1,00 12,13 1,00 1,13
Chondrogenic SOX9 1,00 6,87 1,00 0,65
AGG 1,00 25,58 1,00 3,31
COL1A1 1,00 17,47 1,00 5,36
COL2A1 / 1,00 (Cp=31) / /
Conclusions: In our experimental conditions, hypoxia affects the differ-
entiation potential of BM-MSCs. Adipogenic, osteogenic and chondrogenic
differentiations are absent. Our results may provide information of the
differential molecular mechanisms regulating the MSCs differentiations.
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Purpose: Collagen gels could be used as carriers in cell therapy to improve
cell retention and distribution in the defect. Hydroxyapatite could be added
to gels to improve mechanical properties and reduce gel contraction. The
aim of this work was to analyze the feasibility to incorporate hydroxyap-
atite into collagen gels and culture mesenchymal stem cells inside it.
Methods: Human bone marrow mesenchymal stem cells (MSC) were used
in this study. They were characterized by phenotypic marker analysis
(CD34-, CD45-, HLA-DR-, CD73+, CD90+, CD105+, CD166+) and ostegenic,
chondrogenic and adipogenic differentiation potential. Gels were prepared
by mixing rat tail type I collagen (ColI), hydroxyapatite microparticles
(Hap, 30-80 μm) and MSCs to obtain a ﬁnal concentration of 3mg/ml ColI,
2mg/ml Hap and 5 105 cell/ml. pH was adjusted to 7.0 with NaOH and
350ml of the mixture was distributed on each well of 48-well culture
